Stay updated on Lumateperone Adjunct in Major Depressive Disorder Clinical Trial
Sign up to get notified when there's something new on the Lumateperone Adjunct in Major Depressive Disorder Clinical Trial page.

Latest updates to the Lumateperone Adjunct in Major Depressive Disorder Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page has updated its date references, adding new dates in May 2025 while removing older dates from April 2025.SummaryDifference0.5%
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page has been updated to include new assessment scores for the Montgomery-Åsberg Depression Rating Scale (MADRS) and the Clinical Global Impression Scale-Severity (CGI-S) as of April 29, 2025, while previous versions of these assessments have been removed.SummaryDifference2%
- Check39 days agoChange DetectedThe page has undergone significant changes, including the removal of detailed study information regarding a clinical trial for Major Depressive Disorder and the addition of a new revision number.SummaryDifference29%
- Check46 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check53 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check60 days agoChange DetectedThe webpage has been updated to reflect new results reporting dates, with the most significant date being the estimated results posting on March 25, 2025. Additionally, study documents from Intra-Cellular Therapies, Inc. have been added.SummaryDifference3%
Stay in the know with updates to Lumateperone Adjunct in Major Depressive Disorder Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lumateperone Adjunct in Major Depressive Disorder Clinical Trial page.